Wooten v. Woods

CourtDistrict Court, S.D. Ohio
DecidedJanuary 14, 2022
Docket2:19-cv-00664
StatusUnknown

This text of Wooten v. Woods (Wooten v. Woods) is published on Counsel Stack Legal Research, covering District Court, S.D. Ohio primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Wooten v. Woods, (S.D. Ohio 2022).

Opinion

UNITED STATES DISTRICT COURT SOUTHERN DISTRICT OF OHIO EASTERN DIVISION

COREY WOOTEN,

Plaintiff,

Civil Action 2:19-cv-664 v. Judge Edmund A. Sargus, Jr. Magistrate Judge Elizabeth P. Deavers

DR. BARBARA WOODS, et al.,

Defendants.

REPORT AND RECOMMENDATION

Plaintiff, Corey Wooten, currently incarcerated in the London Correctional Institution, proceeding pro se and in forma pauperis, brings this action under 42 U.S.C. § 1983. (ECF No. 5.) Following an initial screening, Plaintiff is proceeding on his claims as set forth in his Complaint against Defendants Barbara Woods, Robin Murphy, Michael Helberg, John Gardner, and Andrew Eddy in their individual capacities.1 This matter is before the Court for consideration of Defendants’ Motion for Summary Judgment. (ECF No. 54.) Plaintiff has filed a response (ECF No. 58) and Defendants have filed a Reply (ECF No. 59.) For the reasons that follow, it is RECOMMENDED that the Court GRANT Defendants’ Motion for Summary Judgment. I. The following facts, taken from Plaintiff’s unverified Complaint (ECF No. 5), appear to be undisputed. (See ECF No. 54 at 2-4.) Subsequent to his conviction and sentence, Plaintiff

1 Complaint, ECF No. 5, at ⁋ 1. was committed to the custody of the Ohio Department of Rehabilitation and Correction (“ODRC”), and upon his arrival at the Correctional Reception Center (“CRC”) on February 3, 2016, he began receiving treatment for his psoriasis. (ECF No. 5 at ⁋⁋ 6, 7.) Plaintiff’s medical records from Oakview Dermatology, prior to his incarceration, indicated that he was responding well to a treatment plan which included Humira injections, and that other than psoriasis his overall health

was good. (Id. at ⁋⁋at 8, 9.). On April 28, 2016, Plaintiff was transferred from CRC to Chillicothe Correctional Institution (“CCI”), where he began receiving treatment with Methotrexate and cortico steroids. (Id. at ⁋ 11.) This treatment was continued upon Plaintiff’s transfer to LoCI on April 10, 2017. (Id. at ⁋ 12.) On May 4, 2017, Plaintiff was seen by Defendant Woods at LoCI, where Plaintiff requested that he be placed back on Humira because his psoriasis was not responding to Methotrexate. (Id. at ⁋ 13.) Defendant Woods continued his psoriasis treatments using Methotrexate and cortico steroids but also ordered lab tests to monitor Plaintiff’s liver enzymes because Methotrexate may cause liver damage in some patients. (Id. at ⁋ 13) (sic).2 In June of

2017, Defendant Woods raised Plaintiff’s dosage of Methotrexate from 15mg to 20mg because his psoriatic symptoms were not improving. (Id. at ⁋ 14.) Defendant Woods continued to monitor Plaintiff’s liver enzymes, and upon receiving lab results showing elevated liver enzymes, she lowered Plaintiff’s Methotrexate dosage to 10mg. (Id. at ⁋⁋ 14-15.) Plaintiff saw Defendant Woods again in August 2017 and requested to be placed on Humira. (Id. at ⁋⁋ 16, 17.) He complained that he was experiencing an increase in pain and was unable to exercise regularly, which led him to become obese. (Id. at ⁋ 17.). Defendant Woods said that she had reviewed Plaintiff’s medical records and would look into getting him back on

2 Plaintiff’s Complaint contains two paragraphs numbered as 13. Humira and/or requesting that he be seen by a rheumatologist. (Id. at ⁋ 19.) She attempted to receive these authorizations, which needed to be made via Health Care Administrator Murphy by a consult with the Collegial Review Board. (Id. at ⁋ 21.) The Collegial Review Board denied the requests and recommended alternative treatments. (Id. at ⁋ 22.) Plaintiff began experiencing symptoms of psoriatic arthritis and informed Defendant Woods of this in September 2017. (Id. at

⁋ 23.) Defendant Woods again requested that Plaintiff be permitted to see a rheumatologist. The Collegial Review Committee denied this request and recommended an alternative treatment. (Id. at ⁋ 25.) In November 2017, lab results from Plaintiff’s then most recent bloodwork indicated that his “inflammation levels” were six times higher than normal. (Id. at ⁋ 27.) Plaintiff complained again to Defendant Woods that he was in pain and asked that she try another medication. (Id. at ⁋ 28.) In late 2017, Defendant Woods placed Plaintiff back on Methotrexate for a short time, but due to rising liver enzyme levels, he was taken off that medication. (Id. at ⁋ 29.) From approximately December 2017 through May 2018, Plaintiff continued to see Defendant Woods

and informed her that his psoriasis symptoms were continuing to worsen. (Id. at ⁋ 30.) The following additional facts, also apparently undisputed, are taken from the Declaration of Dr. Andrew Eddy, State Medical Director for the ODRC, submitted in support of Defendants’ Motion for Summary Judgment. (Eddy Decl., ECF No. 54-1.) When an inmate at an ODRC institution is diagnosed and treated by a physician at that facility, the diagnosis and treatment- including any prescribed medications- results from that physician’s professional independent medical judgment. (Eddy Decl. at ¶ 5.) ODRC maintains a “Drug Formulary” specifically developed for inmates housed at its correctional institutions. (Eddy Decl. at ¶ 6.) The Formulary lists standardized medications that may be prescribed and dispensed for inmates by advanced-level providers without prior authorization from the ODRC Office of Correctional Health Care. (Id.) ODRC regulations require that medications on the ODRC's Drug Formulary should be used and assessed as a treatment option prior to prescribing non-formulary medications. (Id.at ¶ 8.) Similar to the requirement of many medical insurance providers, medications that are not listed on the Drug

Formulary require prior authorization, which is done through a request from an Advanced Level provider, such as Dr. Woods. (Id. at ¶ 7.) On the ODRC Drug Formulary, Methotrexate and cortico steroids are the medications listed for treatment of psoriasis and rheumatoid arthritis. (Id. at ¶ 10.) Humira is not on the Drug Formulary. (Id.) ODRC policy also dictates that, while outside physicians may make recommendations as to an inmate’s treatment, including pain medication and non-formulary medications, physicians at the individual institutions make the final decision as to treatment based on their own clinical assessment. (Id. at ¶ 11). When an inmate requires outside specialty care, a Consultation Request is generated. Consultation Request forms are used to secure non-ODRC medical specialist care. (Id. at ¶ 12.) If the consultation request is approved by the Collegial Review process, it is sent to ODRC Central Office Scheduling Department who coordinates with the outside facility’s scheduling department. (Id.) The ODRC Central Office contacts the outside specialty provider, who then provides the prison medical department with the date. (Id.) The prison medical staff has no control over an outside medical facility’s scheduling. (Id.) II.

Under Federal Rule of Civil Procedure 56(a), “[t]he court shall grant summary judgment if the movant shows that there is no genuine dispute as to any material fact and the movant is entitled to judgment as a matter of law.” The burden of proving that no genuine issue of material fact exists falls on the moving party, “and the court must draw all reasonable inferences in the light most favorable to the nonmoving party.” Stransberry v. Air Wisconsin Airlines Corp., 651 F.3d 482, 486 (6th Cir. 2011) (citing Vaughn v. Lawrenceburg Power Sys., 269 F.3d 703, 710 (6th Cir.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Estelle v. Gamble
429 U.S. 97 (Supreme Court, 1976)
Jones v. Muskegon County
625 F.3d 935 (Sixth Circuit, 2010)
Alspaugh v. McConnell
643 F.3d 162 (Sixth Circuit, 2011)
Stansberry v. Air Wisconsin Airlines Corp.
651 F.3d 482 (Sixth Circuit, 2011)
James Kimble v. Mark Wasylyshyn
439 F. App'x 492 (Sixth Circuit, 2011)
Tjymas Blackmore v. Kalamazoo County
390 F.3d 890 (Sixth Circuit, 2004)
Miller v. Calhoun County
408 F.3d 803 (Sixth Circuit, 2005)
Jeannie Parsons v. MDOC
491 F. App'x 597 (Sixth Circuit, 2012)
Farmer v. Brennan
511 U.S. 825 (Supreme Court, 1994)
Grinter v. Knight
532 F.3d 567 (Sixth Circuit, 2008)
Robert v. Tesson
507 F.3d 981 (Sixth Circuit, 2007)
Pfahler v. National Latex Products Co.
517 F.3d 816 (Sixth Circuit, 2007)
Lucas Burgess v. Gene Fischer
735 F.3d 462 (Sixth Circuit, 2013)
Oscar Santiago v. Kurt Ringle
734 F.3d 585 (Sixth Circuit, 2013)
Horton v. Martin
137 F. App'x 773 (Sixth Circuit, 2005)
United States v. Sullivan
431 F.3d 976 (Sixth Circuit, 2005)
Dodson v. Wilkinson
304 F. App'x 434 (Sixth Circuit, 2008)

Cite This Page — Counsel Stack

Bluebook (online)
Wooten v. Woods, Counsel Stack Legal Research, https://law.counselstack.com/opinion/wooten-v-woods-ohsd-2022.